Align Capital Partners related stories
All articles and analysis
Align Capital Partners' Advantage Investigations completes add-on of NorStar InvestigationsFishkill, New York-based NorStar provides surveillance, background checks and insurance fraud, claim and legal investigations across New York, New Jersey and Pennsylvania.
Align Capital's MKB Company acquires erosion control maker SiltwormSiltworm, based in Indiana, makes proprietary rolled filter products that control sediment and reduce erosion using lightweight, biodegradable fill material.
Align Capital Partners acquires Trident Solutions in platform investmentPlano, Texas-based Trident Solutions, a manufacturer of branded safety marking, identification and damage prevention products, serves more than 1,700 customers across utility, commercial and industrial end markets.
ACP-backed Marco Sealing Solutions adds Global O-Ring and Seal in bolt-on dealGlobal O-Ring and Seal stocks more than 125 million O-rings for industrial supply chains worldwide from its 52,000-square-foot facility.
Blue Sea Capital completes acquisition of CompletePet from Align Capital PartnersAlign Capital Partners formed CompletePet in 2025 by merging Custom Veterinary Services and Green Mountain Animal.
Align Capital-backed E Source picks up Aneden ConsultingBoulder-based E Source helps utilities optimize the grid.
Thompson Street's ATIS acquires AuditMate to expand elevator asset platformAuditMate, billed as a leading elevator asset management technology platform, helps building owners and property managers track maintenance performance and cut risk.
ACP-backed Marco snaps up industrial products supplier Rocket SealsMarco is a provider of specialty rubber, plastic, and metal components.
ACP-backed Schneider Geospatial picks up govtech firm New England GeoSystemsSchneider Geospatial is a platform of GIS-based SaaS solutions for parcel management, permitting & licensing and asset management serving the government technology sector.
ACP acquires medical tech firm Heritage ImagingHeritage is led by CEO Dr. Steve Coppess, who will continue to lead the company post-transaction alongside the current management team.